Sterling Consolidated Corp. STCC
Last Post: 11/29/2018 11:18:53 AM
Board Marks: 4
Posts Today: 0
Board Views Today: 191
02/13/2017 12:33:16 PM
02/13/2017 12:31:57 PM
02/13/2017 12:31:41 PM
02/10/2017 11:47:55 AM
02/10/2017 11:47:15 AM
02/10/2017 11:05:54 AM
02/10/2017 11:05:22 AM
02/10/2017 11:04:53 AM
02/09/2017 4:39:40 PM
02/09/2017 4:39:22 PM
02/09/2017 4:38:57 PM
02/09/2017 4:37:11 PM
02/09/2017 3:35:18 PM
02/09/2017 3:34:42 PM
02/09/2017 3:34:22 PM
02/08/2017 1:17:00 PM
02/08/2017 11:46:18 AM
02/08/2017 11:44:49 AM
02/08/2017 11:44:31 AM
02/02/2017 11:51:26 AM
11/15/2016 1:11:23 PM
11/15/2016 1:10:42 PM
11/15/2016 1:10:15 PM
11/15/2016 11:45:30 AM
11/15/2016 11:44:44 AM
11/15/2016 11:43:26 AM
11/15/2016 10:19:50 AM
11/15/2016 10:18:12 AM
11/14/2016 1:57:16 PM
11/14/2016 12:42:23 PM
11/14/2016 12:40:21 PM
11/14/2016 12:39:50 PM
11/14/2016 11:24:34 AM
11/14/2016 11:23:44 AM
11/14/2016 11:21:26 AM
11/14/2016 10:31:59 AM
11/14/2016 10:31:06 AM
11/14/2016 10:30:12 AM
11/11/2016 1:41:50 PM
11/11/2016 1:41:11 PM
11/11/2016 1:40:31 PM
11/11/2016 1:39:59 PM
11/11/2016 12:32:35 PM
11/11/2016 12:31:37 PM
11/11/2016 12:31:02 PM
11/11/2016 11:13:34 AM
11/11/2016 11:11:38 AM
11/11/2016 11:11:05 AM
11/10/2016 12:52:38 PM
11/10/2016 12:51:50 PM
Recent Articles
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer
- Vivace Therapeutics Reports Promising Results for VT3989 Therapy
- iOncologi's Patent Enhances Cancer Treatment with mRNA Breakthrough
- Innovative Subcutaneous Therapy Shows Promise in Cancer Treatment
- New Breakthrough Data from Novartis on Prostate Cancer Treatment
